Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

First-in-human study of anticoagulant ONO-7684 successful in healthy subjects

July 21, 2020

Global Blood Therapeutics divulges SLC40A1 inhibitors

July 9, 2020

Phase II results presented for mitapivat in non-transfusion-dependent thalassemia

July 6, 2020

Rapid platelet responses seen with rilzabrutinib in relapsed/refractory immune thrombocytopenia

July 6, 2020

Researchers present preclinical data on EDIT-301 for sickle cell disease

July 1, 2020

Vadadustat approved in Japan for the treatment of anemia due to CKD

June 30, 2020

Japan first to approve Duvroq for anemia due to chronic kidney disease

June 29, 2020

European Commission approves Ultomiris for adults and children with aHUS

June 29, 2020

Reblozyl approved in Europe for transfusion-dependent anemia in MDS or beta-thalassemia

June 29, 2020

First clinical results presented for PXS-5505

June 18, 2020

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...